Evelyn Kelly, CEO and Founder of Orphan Drug Consulting, Nominated as Finalist for Prestigious Founder of the Year Award
Dublin, 19 September 2023 Orphan Drug Consulting is thrilled to announce that our very own CEO and Founder, Evelyn Kelly, has been selected as a finalist for the esteemed Founder of the Year Award, hosted by Enterprise Ireland. This prestigious recognition is an integral part of the HPSU Founders Forum, an annual event that […]
Emerging Biotech achieves successful European launch with support of Orphan Drug Consulting’s comprehensive approach to navigating diverse market landscape and EU regulations
As rare disease companies continue to face the challenge of entering new markets without adequate infrastructure build and knowhow, Orphan Drug Consulting experts recently supported one such company with an accelerated launch into the EU market. Using its cross-functional team and proven approach, Orphan Drug Consulting enabled early access of the client’s treatment to […]
The Role of a Responsible Person (RP) & a Qualified Person (QP)
What is a Marketing Authorization? A marketing authorization (MA) is the authorization from the European Medicines Agency (EMA) which permits a medicine to be sold in one, several, or all the European Union’s member states, depending on the type of application that has been submitted and to which agency. What is a Qualified Person? Under […]
Choosing the Right 3PL Service Provider in Europe
Introduction Extensive growth in the pharmaceutical industry over the last number of years has resulted in an increased demand for third-party logistics (3PL) services as companies began to outsource and adopt more virtual operations. Outsourcing to a third-party logistics provider can often save companies money and time by allowing them to avoid the ongoing investments […]